Why regional stockout diagnosis fails
Regional divergences and noisy alerts prevent proper validation of pharmacy stockouts, creating false alarms and delaying commercial action.
Read the article →Each deck gives the key points of one blog article. You read it in a few minutes.
Regional divergences and noisy alerts prevent proper validation of pharmacy stockouts, creating false alarms and delaying commercial action.
Read the article →
Tax changes generate fears of shortages, but the true risk in pharmacies is the lack of visibility into availability per POS.
Read the article →
Tax reform discussions and stockout risks expose the industry's lack of prior visibility into actual point-of-sale inventory.
Read the article →
BI's demand for data auditing in the pharmaceutical channel makes sense, but trust comes from clarity on limits and sources, not from illusions of perfection.
Read the article →
The rapid expansion of major chains requires looking beyond consolidated revenue and examining actual availability per point of sale.
Read the article →
Stockouts in pharmacies are rarely just an isolated production problem. Learn how to anticipate the risk and protect inventory per POS.
Read the article →
Macroeconomic discussions on the pharmaceutical chain ignore that stockout is a daily issue of visibility and execution.
Read the article →
The growth of digital sales and demand spikes in high turnover categories expose logistical flaws that spreadsheets and static reports cannot solve.
Read the article →
The arrival of new formats in pharmaceutical retail expands capillarity, but exposes the fragility of inventory visibility in newly opened chains.
Read the article →
Learn why stockout in the pharmaceutical channel is often noticed too late and how to anticipate product absence before the customer migrates to a competitor.
Read the article →
Opening new drug sales channels generates a sell-in peak, but silent stockout at the endpoint masks the true product turnover.
Read the article →
Discussing squeezed margins in pharmaceutical distribution without looking at the point of sale just shifts the problem. Learn why channel monitoring is the path.
Read the article →
Digital expansion and the use of AI in pharmacies increased data volume, but did not eliminate stockout. Learn how to structure decisions in the channel.
Read the article →
Demand forecasts in the pharmaceutical channel fail when relying on raw volume without identity governance, EAN, CNPJ, and gap visibility.
Read the article →
Isolated logistics initiatives do not guarantee presence at the point of sale. Discover why the pharmaceutical channel requires recurring intelligence and evidence-based decisions.
Read the article →
Positive annual consolidation masks channel fluctuations. Discover how to separate volatility from stockouts and demand in pharmaceutical operations.
Read the article →
The official supply shortage notice comes late. Discover how channel visibility anticipates stockout signals before they become a crisis.
Read the article →
Discover why looking only at monthly closings hides stockouts and how to anticipate availability risk in the pharma channel.
Read the article →
Specialty product distribution in the pharmaceutical channel fails when the commercial team relies on monthly reports to identify gaps.
Read the article →The entry of digital channels into pharmacy sales expands reach, but raises the risk of hidden stockouts and demands recurring inventory visibility.
Read the article →
Defending data ROI in the pharmacy channel requires showing the cost of deciding late on stockouts, rather than justifying the tool through reporting time savings.
Read the article →